NECO, MCPHS explore joining forces

Article

New England College of Optometry (NECO) and Massachusetts College of Pharmacy and Health Sciences (MCPHS) consider joining forces.

 

Boston-New England College of Optometry (NECO) and Massachusetts College of Pharmacy and Health Sciences (MCPHS) have signed a letter of intent to explore a potential combination.

Officials from both colleges said a natural synergy exists between the institutions to support combining the two schools. The officials also said such a move would create an opportunity to expand NECO’s highly respected brand and expertise in optometry to Worcester.

Steven Manfredi, NECO’s board chairman said, “We are confident that our focus on a high-quality optometry educational experience will be affirmed and that there will be continuity for current students, faculty, and staff.”

Charles F. Monahan, Jr., MCPHS president, said, “We see a bright and growing future for NECO and the continuation of its position as a leader in optometric education, and an opportunity for MCPHS University to continue to expand its depth and breadth in global health care education.”

NECO’s campus is located in Boston’s Back Bay neighborhood. The college provides a 4-year post-baccalaureate curriculum in optometry to about 475 students. MCPHS has campuses in Boston and Worcester, MA, and Manchester, NH. More than 6,000 undergraduate and graduate students are pursuing degrees in approximately 50 academic programs, including optometry, on MCPHS’s three campuses. MCPHS founded its School of Optometry on its Worcester campus on 2011.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.